{"nct_id":"NCT01646125","title":"An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations","status":"TERMINATED","status_verified_date":"2019-07","start_date":"2012-11-23","start_date_type":"ACTUAL","primary_completion_date":"2015-11-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-11-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}